Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
2018 | Transcript : Aevi Genomic Medicine, Inc. - Special Call | |
2018 | Transcript : Aevi Genomic Medicine, Inc., Q4 2017 Earnings Call, Mar 13, 2018 |
Kurzporträt
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 77 713 782 | 59 472 216 ( 76,53 %) | 0 | 76,53 % |
Unternehmenskontakt
Aevi Genomic Medicine, Inc.
435 Devon Park Drive Suite 715
19087, Wayne
+610-254-4201
http://www.medgenics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+34.14% | 51.12 Mrd. | |
-6.54% | 39.4 Mrd. | |
+34.92% | 38.48 Mrd. | |
-12.11% | 26.22 Mrd. | |
+12.62% | 26.36 Mrd. | |
-13.43% | 20.96 Mrd. | |
+43.73% | 14.02 Mrd. | |
+31.81% | 12.49 Mrd. | |
-4.54% | 11.61 Mrd. |